関連する実験動画

Updated: Apr 6, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.3K

バイオプロステスの完全な人工心臓の最初の臨床使用: 2件の症例報告

Alain Carpentier1, Christian Latrémouille1, Bernard Cholley2

  • 1Department of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes-Sorbonne Paris Cité, Paris, France.

Lancet (London, England)
|August 2, 2015
PubMed
まとめ

この研究では,終末期心不全患者の2人のCARMAT全人工心臓 (C- TAH) を評価した. 可能性と血栓の減少の可能性を実証しながら,デバイスの故障は患者の死亡率につながり,全人工心臓開発の課題を強調しました.

さらに関連する動画

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.4K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.1K

関連する概念動画

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
585